Aclaris Therapeutics (ACRS) Reports Q2 Loss of $0.56/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. SPCX
3. MU
4. ACN
5. IBM
6. SPY
7. NVDA
8. PRIM
9. PFE
10. TSLA

Go back to Aclaris Therapeutics (ACRS) Reports Q2 Loss of $0.56/Share
(NASDAQ: ACRS) Delayed: 4.95 +0.11 (2.27%)
Previous Close $4.84    52 Week High $33.88 
Open $4.77    52 Week Low $14.12 
Day High $5.12    P/E N/A 
Day Low $4.77    EPS $0.00 
Volume 833,598